ArticleDiagnostic utility of BRCA1-associated protein 1 (BAP1), Programmed Cell Death4 (PCD4) and Epithelial membrane antigen (EMA) expression in differentiation of malignant mesotheliom
ArticleDiagnostic utility of BRCA1-associated protein 1 (BAP1), Programmed Cell Death4 (PCD4) and Epithelial membrane antigen (EMA) expression in differentiation of malignant mesotheliom
ArticleImmunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological
ArticleImmunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological
ArticleImmunohistochemical study of fibroblast activation protein and α-smooth muscle actin expression and distribution in triple-negative breast cancer
ArticleImmunohistochemical study of fibroblast activation protein and α-smooth muscle actin expression and distribution in triple-negative breast cancer
ArticleImmunohistochemical Expression of CD10 in Invasive Breast Carcinoma: A clinico-Pathologic Study
ArticleImmunohistochemical Expression of CD10 in Invasive Breast Carcinoma: A clinico-Pathologic Study
ArticleImmunohistochemical Study of 5-Methylthioadenosine Phosphorylase (MTAP) and Epithelial Membrane Antigen (EMA) in Differentiating Epithelioid Pleural Mesothelioma from Reactive Me
ArticleImmunohistochemical Study of 5-Methylthioadenosine Phosphorylase (MTAP) and Epithelial Membrane Antigen (EMA) in Differentiating Epithelioid Pleural Mesothelioma from Reactive Me
ArticlePrognostic Significance of Trophoblastic Cell Surface Protein 2 (Trop2) Expression in Breast Cancer and Relation to Microvascular Density
ArticlePrognostic Significance of Trophoblastic Cell Surface Protein 2 (Trop2) Expression in Breast Cancer and Relation to Microvascular Density